A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
Active, not recruiting · NCT05662241 · Registry updated 2026-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease | Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder | Active, not recruiting | Phase 3 | 2026-02-04 | NCT05662241 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Zenas BioPharma (USA), LLC | 6 |
65 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.